Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Changes in neutrophil-to-lymphocyte ratio in patients with polycythemia vera treated with ruxolitinib reflect JAK2 variant allele frequency

Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
FROM Research Foundation, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo
Center Research and Innovation of Myeloproliferative Neoplasms-CRIMM, Department of Clinical and Experimental Medicine, University of Florence, and Hematology Unit, Azienda Ospedaliera Universitaria Careggi, Florence
Haematologica Early view Apr 9, 2026 https://doi.org/10.3324/haematol.2025.300245

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.300245
 
Published
2026-04-09
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
177
PDF Downloads
120
No Data
PlumX
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online